Relapsed or Refractory Diffuse Large B-cell Lymphoma Therapeutics are Poised to Witness High Growth Owing to Advancements in Targeted Therapies
Diffuse large B-cell lymphoma (DLBCL) is an aggressive (fast-growing) type of non-Hodgkin lymphoma (NHL) that develops from B-cells. It makes up about 22% of newly …